Angiotensin II stimulates proliferation of normal early erythroid progenitors

Journal of Clinical Investigation

Volumn 100, Issue 9, 1997, Pages 2310-2314

  Mrug, Michal ^a   Stopka, Tomas ^a   Julian, Bruce A ^b   Prchal, Jaroslav F ^c   Prchal, Josef T ^a,d  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c MCGILL UNIVERSITY   (Canada)

^d University of Alabama at Birmingham   (United States)

Author keywords

Angiotensin receptor; Erythrocytosis; Erythropoiesis; Kidney transplant; Polycythemia

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; CD34 ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; LOSARTAN;

ARTICLE; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; ERYTHROCYTOSIS; ERYTHROID CELL; ERYTHROPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; KIDNEY TRANSPLANTATION; POLYCYTHEMIA; PRIORITY JOURNAL;

EID: 0030671372     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119769     Document Type: Article

References (23)

1. Cashman, J.D., A.C. Eaves, E.W. Raines, R. Ross, and C.J. Eaves. 1990. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-beta. Blood. 75:96-101.
2. Shao, L., N.L. Frigon, Jr., D.W. Sehy, A.L.Yu, J. Lofgren, R. Schwall, and J. Yu. 1992. Regulation of production of activin A in human marrow stromal cells and monocytes. Exp. Hematol. (NY). 20:1235-1242.
3. Clark, S.C., and R. Kamen. 1987. The human hematopoietic colony-stimulating factors. Science (Wash. DC). 236:1229-1237.
4. Bernstein, A., L. Forrester, A.D. Reith, P. Dubreuil, and R. Rottapel. 1991. The murine W/c-kit and Steel loci and the control of hematopoiesis. Semin. Hematol. 28:138-142.
5. Weber, H., D.S. Taylor, and C.J. Molloy. 1994. Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin. J. Clin. Invest. 93:788-798.
6. Jackson, T.R., L.A. Blair, J. Marshall, M. Goedert, and M.R. Hanley. 1988. The mas oncogene encodes an angiotensin receptor. Nature (Lond.). 335: 437-440.
7. Julian, B.A., R.S. Gaston, C.V. Barker, G. Krystal, A.G. Diethelm, and J.J. Curtis. 1994. Erythropoiesis after withdrawal of enalapril in post-transplant erythrocytosis. Kidney Int. 46:1397-1403.
8. Danovitch, G.M., N.J. Jamgotchian, P.H. Eggena, W. Paul, J.D. Barrett, A. Wilkinson, and D.B.N. Lee. 1995. Angiotensin-converting enzyme inhibition in the treatment of renal transplant erythrocytosis. Clinical experience and observation of mechanism. Transplantation (Baltimore). 60:132-137.
9. Conlon, P.J., S.R. Smith, D.W. Butterly, and D.C. Brennan. 1996. Losartan in post transplant erythrocytosis. J. Am. Soc. Nephrol. (Abstr.). 7:1930.
10. Rivalan, J., M.P. Morin, V. Joyeux, and P. Le Pogamp. 1996. Posttransplant erythrocytosis treatment with losartan. J. Am. Soc. Nephrol. (Abstr.). 7: 1939.
11. Liu, Y., J. Phelan, R.C.P. Go, J.F. Prchal, and J.T. Prchal. 1997. Rapid determination of clonality by detection of two closely-linked X chromosome exonic polymorphisms using allele-specific PCR. J. Clin. Invest. 99:1984-1990.
12. Prchal, J.F., and A.A. Axelrad. 1974. Bone-marrow responses in polycythemia vera. N. Engl. J. Med. 289:1382.
13. Eaves, C.J., and A.C. Eaves. 1978. Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human bone marrow and in patients with polycythemia vera. Blood. 52:1196-1210.
14. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.). 227:680-685.
15. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
16. Prchal, J.F., J.W. Adamson, L. Steinman, and P.J. Fialkow. 1976. Human erythroid colony in vilro: evidence for clonal origin. J. Cell Physiol. 89: 489-492.
17. Shibata, H., H. Suzuki, M. Murakami, A. Sato, and T. Saruta. 1994. Angiotensin II type 1 receptor messenger RNA levels in human blood cells of patients with primary and secondary hypertension: reference to renin profile. J. Hypertens. 12:1275-1284.
18. Marrero, M.B., B. Schieffer, W.G. Paxton, L. Heerdt, B.C. Berk, P. Delafomaine, and K.E. Bernstein. 1995. Direct stimulation of Jak/STAT pathway by the angiotensin II ATI receptor. Nature (Lond.). 273:247-250.
19. Wang, Y., K.K. Morella, J. Ripperger, C.F. Lai, D.P. Gearing, G.H. Few, S.P. Campos, and H. Baumann. 1995. Receptors for interleukin-3 (IL-3) and growth hormone mediate an IL-6-type transcriptional induction in the presence of JAK2 or STAT3. Blood. 86:1671-1679.
20. Linnekin, D., S.R. Weiler, S. Mou, C.S. DeBerry, J.R. Keller, F.W. Ruscetti, D.K. Ferris, and D.L. Longo. 1996. JAK2 is constitutively associated with c-Kit and is phosphorylated in response to stem cell factor. Acta. Haematol. (Basel). 95:224-228.
21. Quelle, F.W., N. Sato, B.A. Witthuhn, R.C. Inhorn, M. Eder, A. Miyajima, J.D. Griffinand, and J.N. Ihle. 1994. JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region. Mol. Cell. Biol. 14:4335-4341.
22. Wang, Y., and G.M. Fuller. 1994. Phosphorylation and internalization of gp130 occur after IL-6 activation of Jak2 kinase in hepatocytes. Mol. Biol. Cell. 5:819-828.
23. Jiang, N., T.C. He, A. Miyajima, and D.M. Wojchowski. 1996. The box1 domain of the erythropoietin receptor specifies Janus kinase 2 activation and functions mitogenically within an interleukin 2 beta-receptor chimera. J. Biol. Chem. 271:16472-16476.